Growth Metrics

InspireMD (NSPR) Shares Outstanding (Weighted Average) (2016 - 2025)

InspireMD filings provide 16 years of Shares Outstanding (Weighted Average) readings, the most recent being $64.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 53.42% to $64.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $64.3 million, a 53.42% increase, with the full-year FY2025 number at $64.3 million, up 53.42% from a year prior.
  • Shares Outstanding (Weighted Average) hit $64.3 million in Q4 2025 for InspireMD, up from $58.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $64.3 million in Q4 2025 to a low of $1.8 million in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $16.7 million (2023), compared with a mean of $22.1 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 1886.58% in 2021 and later plummeted 75.07% in 2022.
  • InspireMD's Shares Outstanding (Weighted Average) stood at $7.3 million in 2021, then grew by 7.16% to $7.9 million in 2022, then skyrocketed by 208.29% to $24.3 million in 2023, then skyrocketed by 72.77% to $41.9 million in 2024, then surged by 53.42% to $64.3 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $64.3 million (Q4 2025), $58.2 million (Q3 2025), and $51.0 million (Q2 2025) per Business Quant data.